Tuesday, July 13, 2021

 

Emily Murphy statue in Edmonton defaced with red paint

The Emily Murphy statue in Edmonton defaced with red paint and the word "racist" Tuesday, July 13, 2021. Global News

A statue of Emily Murphy in Edmonton’s river valley has been defaced with red paint.

Red paint covered the Emily Murphy statue Tuesday morning and the word “racist” was written on the plaque on its base.

Murphy was one of the Famous Five behind the Persons Case, a campaign to have women declared persons in the eyes of British law. However, her views on immigration and eugenics have been criticized as racist and elitist.

“Emily Murphy, along with all the Famous Five and most social reformers of the period, ascribed to the philosophy of eugenics; this idea that there was superiority of the races and, in particular, people of northern European Christian decent were superior,” explained Rebecca Sullivan, a professor in the Gender and Sexual Studies program at the University of Calgary.

“They tried all different kinds of ways to prove that they were superior. I’m sure many of you have heard about the idea of being high brow versus low brow — that actually comes from physically measuring the forehead with calipers to prove that white northern European-decent people had higher foreheads because they had bigger brains.”

READ MORE: Winston Churchill statue in downtown Edmonton vandalized with red paint

Sullivan said using the word racist to describe Murphy “is not inaccurate,” pointing to a publication called The Black Candle. Under the pseudonym Janey Canuck, Sullivan said Murphy wrote the piece which focuses on the drug trade and criminalization of illegal drugs.

Sullivan said the piece “singles out in particular Chinese, Greek… and of course African immigrants, were all targeted in this piece as genetically inferior and therefore more susceptible to vice.”

“It framed it all around moral superiority, and intellectual inferiority, like the inability of racialized immigrants and First Nations to withstand these vices and that they were bringing the rot into Canadian society — meaning white Christian society, fair-complexioned.

“There’s no two ways to read The Black Candle. It’s just full-blown racist.”

ABOUT THE WHITE SLAVE TRADE, RUN BY ORIENTALS WHO IMPORTED OPIUM AND MARIJUANA. AS A RESULT SHE INTRODUCED THE NARCOTICS ACT IN CANADA.

Sullivan said removing the statue will not erase history and she would like to see larger conversations around figures like Murphy.

“What I want to do with the history of Emily Murphy is understand it in a much more comprehensive and complex manner,” she said.

“Does that mean that maybe we stop for a while with statues and parks being named after people who caused a lot of harm? Sure. Will we continue to teach Emily Murphy in the classroom? I will. Nobody is saying don’t teach Emily Murphy. Nobody is saying don’t teach the Famous Five or the Persons Case. We’re saying teach it better.”

Murphy was born on March 4, 1868 in Cookstown, Ont., and died in Edmonton on Oct. 27, 1933.

Late Tuesday afternoon, city manager Andre Corbould issued a statement about the statue being vandalized and acknowledged “the strong emotions and polarizing opinions that arise when we consider the attitudes and beliefs of historical figures whose actions no longer reflect our modern ideas and values.”

“We are listening to these concerns and are taking steps to determine how to handle these issues through our work in revising our Naming Committee Bylaw under City Policy C509B, and our Statuary Policy C459,” he said. “But this type of work takes time and must include the voices of all Edmontonians, not just those who believe they can solve such concerns through damage or destruction.

“Criminal acts will not drive city policy.”

Corbould said while attitudes and values evolve over time, government’s must keep pace, but also noted “that can’t happen overnight.”

“We ask for people’s understanding and patience so that the solutions we develop reflect our broader society,” he said.

“Vandalism solves nothing. It destroys property, it destroys the hard work of the artist who created the monument or statue and it causes greater anger and frustration.”

In a statement, the City of Edmonton also said the naming and the potential renaming of any park or place is an in-depth process that requires “engagement, research and community buy-in.”

Names can be submitted by residents, organizations, community leagues, developers and city departments.

The city is undertaking a review of the policy that outlines what kind of statues and monuments can be erected in the city. It was last updated in 1990.

“Current plans are for an amendment of the policy and procedures in 2022 to better reflect the current environment and city policy frameworks like the diversity and inclusion policy and the Indigenous framework,” the statement read.

Part of the revised policy will include procedures for dealing with complaints or concerns about specific statues or monuments. The public will be consulted during the process, the city said.

The Edmonton Arts Council was responsible for the cleanup of the statue, which was completed by Tuesday afternoon. The EAC estimates the cleanup cost about $1,200.

The statue is located in Emily Murphy Park on the south bank of the North Saskatchewan River.

It’s now known exactly when the statue was defaced. A spokesperson with the Edmonton Police Service said Tuesday afternoon that she could not confirm whether the incident was reported to police.

– With files from Phil Heidenreich, Global News and Kirby Bourne, 630 CHED

The Emily Murphy statue in Edmonton defaced with red paint and the word "racist" Tuesday, July 13, 2021. Global News
The Emily Murphy statue in Edmonton defaced with red paint and the word "racist" Tuesday, July 13, 2021. Global News
The Emily Murphy statue in Edmonton defaced with red paint and the word "racist" Tuesday, July 13, 2021. Global News
The Emily Murphy statue in Edmonton defaced with red paint and the word "racist" Tuesday, July 13, 2021. Global News
The Emily Murphy statue in Edmonton defaced with red paint and the word "racist" Tuesday, July 13, 2021. Global News

Gen Z, millennials playing a significant part in the Great Resignation trend

One-third of employed generation Z and millennial professionals polled reported plans to pursue a new job

THE CANADIAN PRESS
Jul. 13, 2021 

Vanessa Staniforth is shown in the garden at her home in Ottawa, on Friday, July 9, 2021. THE CANADIAN PRESS/Justin Tang

As the COVID-19 pandemic dragged on over the past 16 months, Vanessa Staniforth experienced both burnout and career stagnation in her job.

“I started to feel stuck,” said the 30-year-old Ottawa-based software developer. “There weren’t many opportunities to step out of daily work to expand skills. I had to commit to learning new skills outside of work to satisfy that desire and gain the confidence to even apply for other positions.”

Staniforth, who left her job in April to start a career in a new industry, says she believes the pandemic gave many people a chance to reflect on their work life.


“People are asking themselves: ‘Is this really where I want to be? Is this the right direction for me?’” she said.

Her experience is part of a phenomenon being dubbed the Great Resignation, a wave of workers in Canada and the U.S. who are leaving their jobs, and younger Canadians are contributing to the trend.

According to a recent survey in Canada from global staffing firm Robert Half, 33 per cent of employed generation Z and millennial professionals polled reported plans to pursue a new job. The survey revealed that gen Z mostly wants a change so they can earn a higher salary (40 per cent) while millennials are struggling with low morale (31 per cent).

Staniforth’s former employer was in talks to bring employees back to the office eventually, either full time or with a hybrid work model, but her preference was to remain working from home. She was also looking for a company that could maintain a good company culture for remote workers.

What stood out to Staniforth about her new employer, aside from a fully remote work environment, was that the company promotes diversity and inclusion, offers continuous learning opportunities, celebrates and recognizes good work and encourages rest among its employees.

The position also offered other perks, including a higher salary, flexible time off, restricted stock units, a generous yearly “lifestyle” spending allowance and supplemented parental leave.

Yiorgos Boudouris, a self-employed career coach and head of recruitment at Toronto-based software company Forma AI, said he is constantly having conversations with young professionals who are anxious about their employers’ return-to-office policies.


“I think the pressure is building for folks in that they’re wondering, ‘What will things look like for me and my role once life moves back into some form of normalcy?’” Boudouris said.

With the rise of remote work, many people are also quitting right now because they have the option to work for companies that they never thought possible, Boudouris added. As a result, employers are feeling the pressure to retain employees.

“Employers are going to have to be accommodating to employee needs. That’s why I think if you’re employed right now and there might be some things that you hope to see evolve in your workplace, that accommodation factor might be greater because it’s going to be really hard to find replacements for all the folks who have thoughts about leaving. That retention piece is where I think employees have a lot of power,” he said.

Boudouris’ advice for young professionals is to remind employers about the level of impact that they’ve had and will continue to have on the organization, and explain how certain incremental changes, such as introducing hybrid work options, flexible paid time off, flexible working hours, and employee-directed budgets that support learning and growth, will make them perform even better in their role.

That said, it’s not always worth asking for a change if you’re ready to go.

“When you wake up in the morning, is there a level of enthusiasm for starting your work? And, when you close your laptop that night, do you look back at the day and think it was a good day, or do you think you misplaced your time?” Boudouris said.

“If you’re answering those questions and it’s not looking like you’re deriving satisfaction for what you’ve done that day, then I think it probably tells you that either working for that organization or doing the type of work that you’re doing isn’t what you should be spending your time on.”

Leah Golob, The Canadian Press




Some sea-level rise solutions may exacerbate coastal flooding
By
Brooks Hays



Researchers say that directing flood waters to less vulnerable land, rather than building taller seawalls, in places like the San Francisco Bay could help protect shorelines more effectively. File Photo by Terry Schmitt/UPI | License Photo

July 12 (UPI) -- Some strategies for combating sea-level rise can have unintended consequences, worsening flood conditions in neighboring cities, towns and neighborhoods, according to a new study.

For example, new research -- published Monday in the journal Proceedings of the National Academy of Sciences -- seawalls along the San Francisco Bay shoreline could exacerbate flood damages across the region.

In coastal bay communities like San Francisco, researchers suggest it may be best to direct flood waters to less vulnerable land, rather than build defenses.

"It's not practical to keep building taller and taller seawalls to hold back the ocean," senior study author Anne Guerry said in a press release.

"Our goal was to show how the threat of sea-level rise is interconnected with the whole social-ecological system of the Bay Area. Communities need to coordinate their approaches to sea-level rise adaptation so we can find solutions that are best for the whole bay," said Guerry, chief strategy officer and lead scientist at the Stanford Natural Capital Project.

Models predict sea levels across the San Francisco Bay will rise some seven feet by the end of the century, putting millions of people and hundreds of billions of dollars worth of real estate and infrastructure at risk.


To help city leaders and policy makers develop effective sea-level rise mitigation plans, researchers at Stanford deployed complex mathematic models to simulate how seawall construction would influence the flow of floodwaters in the Bay Area.

RELATED Rising seas, lunar wobble to increase U.S. coastal flooding in 2030s, NASA says

The models showed that should seawalls be built along the San Jose shoreline, communities throughout the region, from Napa to Redwood City, would suffer an additional $723 million in flood damage after just a single high tide.

According to the authors of the new study, seawalls can impede the movement of important bird and fish species. Seawalls can also degrade wetlands, which store carbon and remove pollutants for local waterways.

"You may be protecting your immediate community, but you may be creating serious costs and damages for your neighbors," study co-author Robert Griffin said in the press release.

RELATED Forecast predicts global increase in coastal overtopping


"When it comes to current sea-level rise planning, there's some incomplete cost-benefit accounting going on," said Griffin, an economist at the Natural Capital Project.

Researchers with the Natural Capital Project found communities could avoid excess flood damages by directing floodwaters toward overflow zones such as the Napa-Sonoma shoreline.

Currently, the shoreline is home to Highway 37. Local decision makers are considering whether to build a taller embankment or construct a causeway that would raise the road while allowing excess water to flow inland.

Models suggest an embankment would worsen flooding in bayside communities, while allowing the Napa-Sonoma shoreline to serve as a strategic flood area could prevent millions of dollars in flood damage.

"It's critical to consider the regional impacts of local actions," said lead author Michelle Hummel, assistant professor at the University of Texas at Arlington. "Studies like ours can identify actions that will have large impacts, either positive or negative, on the rest of the bay and help to inform decisions about how to manage the shoreline."

Strategic flooding won't work everywhere, so decision makers considering the unorthodox approach must work with experts to ensure there are sufficient valleys and flood plains that can serve as overflow zones.

Policy makers must also think about how different mitigation strategies will affect various communities.

The authors of the latest study suggest local leaders must work with demographers to ensure flood control efforts don't negatively impact the most vulnerable communities -- neighborhoods already subject to environmental inequities.

As such, flood mitigation planning should be coordinated with broader efforts to build just and sustainable cities.

Moving forward, researchers with the Natural Capital Project plan to model the effects of sea-level rise adaptations on infrastructure, employment and community dynamics.


"Our plans should be as interconnected as our ecosystems," said Guerry.
SPEAKING OF SNAKE OIL
Hydroxychloroquine, remdesivir fail to improve COVID-19 outcomes in study



A new study found little benefits associated with the drugs hydroxychloroquine, pictured, or remdesivir, in patients with severe COVID-19. Photo by UPI


July 12 (UPI) -- Neither remdesivir nor hydroxychloroquine boosts recovery in patients hospitalized with COVID-19, according to the findings of a clinical trial led by the World Health Organization, and published Monday by the Annals of Internal Medicine.

Nearly 8% of patients treated with hydroxychloroquine and just over 7% of those given remdesivir died in the hospital, the data showed.

In comparison, between 4% and 7% of those who received "standard care" -- typically treatment with steroids and other drugs to reduce inflammation and manage respiratory symptoms -- died during their hospital stay, the researchers said.


Similarly, 10% of those given remdesivir and 15% of those who received hydroxychloroquine required mechanical ventilation to breathe, compared with 7% to 11% of those treated with standard care, they said.

"Despite the early emergence of reports that both remdesivir and hydroxychloroquine effectively exerted strong antiviral activities against [the coronavirus] ... our results show no antiviral effects of these drugs in hospitalized patients," the researchers, from Norway, wrote.

"Our findings question the antiviral potential of these drugs in hospitalized patients with COVID-19," they said.

The U.S. Food and Drug Administration approved remdesivir, an antiviral drug originally developed to treat the Ebola virus, for use in people hospitalized due to severe COVID-19 in October.

Since then, though, the drug has produced mixed results in clinical trials, and the WHO recommended against its use in November.

The agency issued the recommendation after initial results from its 30-country "Solidarity" study found that its use has no significant impact on mortality, length of hospital stay or need for ventilation among hospitalized patients.

The malaria drug hydroxychloroquine, meanwhile, was touted as a potential COVID-19 cure by then-President Trump and others early in the pandemic, despite the lack of clinical trial data suggesting that it is any more effective than placebo, or a fake treatment, at promoting recovery.

For this study, researchers from Oslo University Hospital in Norway and 22 other facilities randomly assigned 181 hospitalized patients to receive remdesivir, hydroxychloroquine or standard care.

Study participants accounted for nearly one-fourth of all people hospitalized due to the virus in Norway between March 28 and Oct. 4 of last year.

There were no significant differences between treatment groups in terms of rates of death during hospitalization, the data showed.

Remdesivir and hydroxychloroquine did not affect the degree of respiratory failure or inflammation among patients given the drugs, compared with those who received standard care, the researchers said.

In addition, patients in all three groups had similar decreases in viral load, or the levels of virus, in the nose and throat during the first week of treatment as well as at 10 days.

The lack of antiviral effect with remdesivir and hydroxychloroquine remained consistent across patients of different ages as well as those with distinct symptom duration, viral loads and levels of antibodies, or cells produced by the immune system to fight off viruses, according to the researchers.

"The overall lack of effect of remdesivir and hydroxychloroquine on the clinical course of patients hospitalized for COVID-19 was accompanied by a paucity of effect on ... viral clearance in the [nose and throat]," they wrote.
WITH NO VACCINE RELYING ON SNAKE OIL
North Korea to increase production of traditional medicines, state media says
THEY COULD ASK CHINA OR RUSSIA



North Korea’s state media said Tuesday domestically developed remedies are to be produced in greater quantities. File Photo by How Hwee Young

July 13 (UPI) -- North Korea plans to ramp up production of traditional herbal remedies, state media said.

Korean Workers' Party newspaper Rodong Sinmun reported Tuesday that the production of traditional Korean medicine is a "very important" task for the regime to "make the people aware of the superiority of the socialist system."

The paper also said that at the Third Plenary Meeting of the Eighth Central Committee of the Party in June, a decision was made to produce "highly efficient Korean medicines at various Korean medicine production bases."

"Now is the time for all workers and employees in the Korean medicine sector to become more conscious of the Party and the people's expectations for the development of the health industry," the Rodong said.

"They should double efforts to increase the efficacy of drugs and increase the production of medicines."


North Korea previously touted the effectiveness of Korean medicines. In February, the Rodong said traditional remedies could be used to cure "respiratory diseases" that occur in winter.

In 2015, during South Korea's MERS epidemic, North Korea claimed its independently developed Kumdang No. 2 vaccine could prevent MERS, SARS, AIDS and pneumonia.

Pyongyang began to promote Kumdang No. 2 as a panacea in 2003, when the SARS epidemic was reported in Hong Kong and China. The vaccine again emerged as an antidote in 2006 and 2013, when cases of avian flu threatened global populations.

The North Korean vaccine was not mentioned Tuesday.

One shot of the Sputnik V vaccine triggers strong antibody responses

CELL PRESS

Research News

IMAGE

IMAGE: THIS GRAPHICAL ABSTRACT SHOWS ANTIBODY RESPONSES TO SPUTNIK V VACCINE IN ARGENTINA. ON THE TOP, SCHEMATIC REPRESENTATION OF THE TWO-COMPONENT ADENOVIRUS BASED VACCINE (RAD26 AND RAD5) SPUTNIK V. BOTTOM, IGG... view more 

CREDIT: ROSSI AND OJEDA ET AL./CELL REPORTS MEDICINE

A single dose of the Sputnik V vaccine may elicit significant antibody responses against SARS-CoV-2, finds a study published July 13 in the journal Cell Reports Medicine.

"Due to limited vaccine supply and uneven vaccine distribution in many regions of the world, health authorities urgently need data on the immune response to vaccines to optimize vaccination strategies," says senior author Andrea Gamarnik (@GamarnikLab) of the Fundación Instituto Leloir-CONICET in Buenos Aires, Argentina. "The peer-reviewed data we present provide information for guiding public health decisions in light of the current global health emergency."

Past research has shown that two doses of Sputnik V results in 92% efficacy against coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2. An important question is whether a single dose would achieve greater public health benefit than two doses by allowing protection of a larger population more quickly.

Evidence from other vaccines offers support for the one-shot approach. The AstraZeneca vaccine shows 76% efficacy after a single dose, and the Moderna and Pfizer vaccines may induce sufficient immunity in previously infected individuals after one dose, with no apparent benefit of an additional dose.

In the Cell Reports Medicine study, Gamarnik and her colleagues compared the effects of one and two shots of Sputnik V on SARS-CoV-2-specific antibody responses in 289 healthcare workers in Argentina. Three weeks after the second dose, all volunteers with no prior infection generated virus-specific immunoglobulin G (IgG) antibodies - the most common type of antibody found in blood.

But even within three weeks of receiving the first dose, 94% of these participants developed IgG antibodies against the virus, and 90% showed evidence of neutralizing antibodies, which interfere with the ability of viruses to infect cells.

Additional results showed that IgG and neutralizing antibody levels in previously infected participants were significantly higher after one dose than those in fully vaccinated volunteers with no history of infection. A second dose did not increase the production of neutralizing antibodies in previously infected volunteers.

"This highlights the robust response to vaccination of previously infected individuals, suggesting that naturally acquired immunity might be enhanced sufficiently by a single dose, in agreement with recent studies using mRNA vaccines," Gamarnik says.

Further studies are needed to evaluate the duration of the immune response and to assess how antibody levels relate to vaccine protection against COVID-19. "Evidence based on quantitative information will guide vaccine deployment strategies in the face of worldwide vaccine supply restriction," Gamarnik says.

###

This work was supported by the National Institutes of Health (NIAID) and by the National Ministry of Science Technology and Innovation of Argentina.

Cell Reports Medicine, Rossi and Ojeda et al.: "Sputnik V Vaccine Elicits Seroconversion and Neutralizing Capacity to SARS-CoV-2 after a Single Dose" https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(21)00208-1

Cell Reports Medicine (@CellRepMed), published by Cell Press, is a new, monthly, premium open-access journal from Cell Press publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine. Visit: https://www.cell.com/cell-reports-medicine/home. To receive Cell Press media alerts please contact press@cell.com.

Google trends, the COVID-19 vaccine and infertility misinformation

Researchers document a nearly 35,000% increase in COVID-19 vaccine and infertility Google searches following a misinformation event

AMERICAN OSTEOPATHIC ASSOCIATION

Research News

Google searches related to infertility and coronavirus (COVID-19) vaccines increased by 34,900% after a pair of physicians submitted a petition questioning the safety and efficacy data of the COVID-19 Pfizer vaccine. Referencing the petition, anti-vaccine activists circulated claims that misconstrued the information regarding the possibility that the vaccine could impact fertility in women.

The inaccurately represented information spread rapidly on social media channels, potentially influencing public perception and decision-making among pregnant patients or those seeking to become pregnant, according to research published in the Journal of Osteopathic Medicine. This happened despite the fact that the European Medicines Agency (EMA) and the US Food and Drug Administration issued emergency use authorization for the vaccine, deeming the concerns in the petition insignificant.

"Misinformation is a significant threat to healthcare today and a main driver of vaccine hesitancy," said Nicholas Sajjadi, a study researcher and third-year osteopathic medical student at Oklahoma State University College of Osteopathic Medicine. "We're seeing well-intentioned research and concerns taken out of context to stoke fear and anxiety about vaccination."

The making of a misinformation campaign

On December 1, 2020, Drs. Wolfgang Wodarg and Michael Yeadon petitioned to withhold emergency use authorization of the BNT162b2 mRNA vaccine for COVID-19 manufactured by BioNTech and Pfizer. The petitioners raised unfounded concerns that female infertility could arise from vaccine-induced antibodies. It is important to note that the petitioners acknowledged the absence of any evidence associating female infertility risks with COVID-19 vaccines.

Anti-vaccine advocates seized on this concern to create a misinformation claim misrepresenting the EMA petition, and the public turned to Google to understand if the information was legitimate. At peak interest, the Google search terms "infertility," "infertility AND vaccine," and "infertility AND COVID vaccine" experienced increases of 119.9%, 11,251%, and 34,900%, respectively, when compared with forecasted values.

"I'm disappointed this misinformation occurred, but I am pleased to see spikes in searches because it reflects genuine interest and suggests that people are doing their research and trying to make informed decisions," said J. Martin Beal, DO, an OB-GYN with Tulsa OB-GYN Associates. "What I'd like to emphasize to patients is that your doctor would love to have this conversation with you to help clarify any questions or concerns you may have. Additionally, I highly encourage getting vaccinated--it will protect you and the baby."

Support for COVID-19 vaccination during pregnancy

The American College of Obstetricians and Gynecologists currently recommends that COVID-19 vaccines not be withheld from pregnant patients who meet criteria for vaccination based on priority groups recommended by the Advisory Committee on Immunization Practices and those at increased risk for COVID-19 acquisition, such as women healthcare workers.

"Dispelling misinformation and informing patients about the risks and benefits of COVID-19 vaccination, or other misrepresented claims, can save lives and slow the spread of disease," said Sajjadi. "In the battle to fight misinformation, Google Trends can be an effective tool to help physicians recognize and proactively address false claims with patients."

###

About the Journal of Osteopathic Medicine

The Journal of Osteopathic Medicine, founded in 1901 and known for 119 years as The Journal of the American Osteopathic Association, is the premier scholarly, peer-reviewed publication of the osteopathic medical profession. JOM conducts peer review of academic research manuscripts from a wide variety of medical specialties, covering the full spectrum of clinical settings in which osteopathic physicians practice. All submissions are vetted by a distinguished group of Section Editors led by Editor-in-Chief Ross Zafonte, DO, and supported by a full Editorial Board.

Media Contact

Jessica Bardoulas, Senior Director of Public Relations, American Osteopathic Association jbardoulas@osteopathic.org | (312) 202-8038